维普中文期刊产品整合服务
20篇 您的检索式:作者名="TANNHEIMER SL"
    题名 作者 年代 出处 被引量
1Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells显示文摘Moffa AB Tannheimer SL Ethier SP 0,,11:1
2Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE显示文摘Tannheimer SL Rehemtulla A Ethier SP 0,,04:1
3et al Factors in uencing elevation of intracellular Ca 2+ in the MCF-10A hu- man mammary epithelial cell line by carcinogenic polycyclic aromatic hy- drocarbons 显示文摘TANNHEIMER SL LAUER FT LANE J 1999Mol Carcinogen1999,25,:1
4Combination of roflumilast with a beta-2 adrenergie receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts显示文摘Tannheimer SL Wright CD Salmon M 2012Respir Res2012,13,1:1
5Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells 显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Cancer Res2004,2,11:1
6Transforming potential of alternatively spiced variants of FGFR2 in human mammary epithelial cells 显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Cancer Res2004,2,:1
7Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits pro inflammatory and profihrotic mediator release from human lung fibroblasts 显示文摘Tannheimer SL Wright CD Salmon M 2012Respir Res2012,13,1:1
8Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE 显示文摘Tannheimer SL Rehemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
9Characterization of fibroblast growth factor receptor2overexpression in the human breast cancer cell line SUM-52PE显示文摘Tannheimer SL Rehemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
10Transforming potential of alternatively spliced variants of fibroblast gowth factor receptor 2 in human mammary epithelial cells显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Gancer Res2004,2,11:1
11Transforming potential of alternatively spliced variants of FGFR2 in human mammary epithelial cells显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Cancer Res2004,2,:1
12Additive anti inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells显示文摘Tannheimer SL Sorensen EA Haran AC 0,,:1
13Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE 显示文摘Tannheimer SL Rchemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
14Transforming potential of alterna- tively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells 显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Cancer Res2004,2,11:1
15Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells 显示文摘Moffa AB Tannheimer SL Ethier SP 2004Mol Cancer Res2004,2,11:1
16Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE显示文摘Tannheimer SL Rehemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
17Additive antiinflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells 显示文摘Tannheimer SL Sorensen EA Haran AC 2012Pulm Pharmacol Ther2012,25,2:1
18Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE显示文摘Tannheimer SL Rehemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
19Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE显示文摘Tannheimer SL Rehemtulla A Ethier SP 2000Breast Cancer Res2000,2,4:1
20Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts显示文摘Tannheimer SL Wright CD Salmon M 0,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费